urea has been researched along with melphalan in 15 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 13 (86.67) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (6.67) | 24.3611 |
| 2020's | 1 (6.67) | 2.80 |
| Authors | Studies |
|---|---|
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Karaivanov, L | 1 |
| Hobbs, JR | 1 |
| Chirigos, MA; Gibson, WT; Pearson, JW | 1 |
| Burns, BC; Rutledge, F; Smith, JP; Soffar, S | 1 |
| Wetter, O | 1 |
| Alexanian, R; Haut, A; Khan, AU; Lane, M; McKelvey, EM; Migliore, PJ; Stuckey, WJ; Wilson, HE | 1 |
| Clifford, P; Klein, G; Singh, S; Stjernswärd, J | 1 |
| Harris, DC; Ibels, LS; Isbister, JP; Ravich, RB; Wells, JV | 1 |
| Collins, FG; Skibba, JL | 1 |
| Buckman, R; Cuzick, J; Galton, DA | 1 |
| Du, J; Fan, J; Huang, H; Li, M; Liu, B; Long, S; Peng, X; Sun, W; Tong, Y; Wang, L | 1 |
4 trial(s) available for urea and melphalan
| Article | Year |
|---|---|
Report on the first myelomatosis trial. I. Analysis of presenting features of prognostic importance.
Topics: Adult; Aged; Alkaline Phosphatase; Bence Jones Protein; Calcium; Cyclophosphamide; Female; Hemoglobins; Humans; Immunoglobulin M; Male; Melphalan; Middle Aged; Multiple Myeloma; Prognosis; Proteinuria; Radiography; Serum Albumin; Urea | 1973 |
Myelomatosis: comparison of melphalan and cyclophosphamide therapy.
Topics: Clinical Trials as Topic; Cyclophosphamide; Humans; Melphalan; Multiple Myeloma; Prognosis; Time Factors; Urea | 1971 |
Treatment for multiple myeloma. Combination chemotherapy with different melphalan dose regimens.
Topics: Bence Jones Protein; Blood Protein Electrophoresis; Blood Proteins; Humans; Immunoelectrophoresis; Melphalan; Multiple Myeloma; Prednisone; Urea | 1969 |
Report on the second myelomatosis trial after five years of follow-up. Medical Research Council's Working Party on Leukaemia in Adults.
Topics: Aged; Clinical Trials as Topic; Cyclophosphamide; Drug Therapy, Combination; Follow-Up Studies; Hemoglobinometry; Humans; Immunoglobulin M; Kidney Diseases; Melphalan; Middle Aged; Multiple Myeloma; Prednisone; Prognosis; Proteinuria; Urea | 1980 |
11 other study(ies) available for urea and melphalan
| Article | Year |
|---|---|
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
[Effect of physical and chemical factors on Pasteurella multocida bacteriophages].
Topics: Acridines; Bacteriophages; Citrates; Culture Media; Gentian Violet; Hydrogen-Ion Concentration; Melphalan; Methylene Blue; Pasteurella; Potassium Permanganate; Pyronine; Rosaniline Dyes; Temperature; Tetracycline; Urea | 1976 |
Monitoring myelomatosis.
Topics: Bence Jones Protein; Bone Neoplasms; Clone Cells; Hemoglobins; Humans; Immunoglobulin A; Immunoglobulin G; Melphalan; Monitoring, Physiologic; Multiple Myeloma; Myeloma Proteins; Prognosis; Serum Albumin; Urea | 1975 |
Use of a murine sarcoma virus in an in vivo assay for antiviral and antitumor agents.
Topics: Animals; Antineoplastic Agents; Antiviral Agents; Biological Assay; Female; Gammaretrovirus; Liver; Male; Melphalan; Mice; Nitroso Compounds; Organ Size; Sarcoma, Experimental; Splenic Neoplasms; Splenomegaly; Time Factors; Urea; Virus Replication | 1970 |
Systemic chemotherapy for carcinoma of the cervix.
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Agents; Carcinoma, Squamous Cell; Cyclophosphamide; Female; Fluorouracil; Humans; Hydroxyurea; Mechlorethamine; Melphalan; Methotrexate; Middle Aged; Neoplasm Metastasis; Neoplasm Recurrence, Local; Progestins; Thiotepa; Urea; Uterine Cervical Neoplasms | 1967 |
Fragments of Bence-Jones proteins: products of degradation or of synthesis by plasmocytoma cells?
Topics: Animals; Bence Jones Protein; Chromatography, Gel; Electrophoresis; Gels; Humans; Immune Sera; Immunochemistry; Immunoelectrophoresis; Melphalan; Multiple Myeloma; Peptides; Propionates; Rabbits; Starch; Ultracentrifugation; Urea | 1970 |
Long-term survival of patients with Burkitt's lymphoma: an assessment of treatment and other factors which may relate to survival.
Topics: Adolescent; Antineoplastic Agents; Burkitt Lymphoma; Busulfan; Child; Child, Preschool; Chlorambucil; Cyclophosphamide; Cytarabine; Female; Humans; Immunotherapy; Infant; Kenya; Male; Mannitol; Melphalan; Methotrexate; Nitrogen Mustard Compounds; Nitroso Compounds; Urea | 1967 |
Multiple myeloma with renal failure. A case for intensive treatment.
Topics: Adult; Aged; Creatinine; Diuretics; Female; Humans; Kidney Failure, Chronic; Male; Melphalan; Middle Aged; Multiple Myeloma; Peritoneal Dialysis; Prednisone; Prognosis; Time Factors; Urea | 1983 |
Altered hepatic functions and microsomal activity in perfused rat liver by hyperthermia combined with alkylating agents.
Topics: Alkylating Agents; Animals; Antipyrine; Biotransformation; Cyclophosphamide; Gluconeogenesis; Liver; Male; Mechlorethamine; Melphalan; Microsomes, Liver; Oxygen Consumption; Rats; Urea | 1983 |
Long-term survival in myelomatosis. A report to the MRC working party on leukaemia in adults.
Topics: Aged; Bence Jones Protein; Cyclophosphamide; Female; Hemoglobins; Humans; Immunoglobulin G; Kidney Failure, Chronic; Leukemia, Myeloid, Acute; Male; Melphalan; Middle Aged; Multiple Myeloma; Paraproteins; Prognosis; Time Factors; Urea | 1982 |
Urea-Bond Scission Induced by Therapeutic Ultrasound for Biofunctional Molecule Release.
Topics: Alkylating Agents; Amines; Melphalan; Methylene Blue; Prodrugs; Urea | 2022 |